Bath & Body Works, Inc. (NYSE:BBWI – Get Free Report)’s stock price gapped down before the market opened on Thursday following a weaker than expected earnings announcement. The stock had previously closed at $21.04, but opened at $15.86. Bath & Body Works shares last traded at $15.95, with a volume of 12,595,127 shares trading hands.
The company reported $0.35 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.40 by ($0.05). The business had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.64 billion. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The firm’s revenue for the quarter was down 1.0% compared to the same quarter last year. During the same period last year, the business posted $0.49 EPS. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS. Q4 2025 guidance at 1.700- EPS.
Bath & Body Works Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, December 5th. Stockholders of record on Friday, November 21st will be paid a $0.20 dividend. The ex-dividend date of this dividend is Friday, November 21st. This represents a $0.80 dividend on an annualized basis and a dividend yield of 4.9%. Bath & Body Works’s dividend payout ratio is 23.74%.
Analyst Upgrades and Downgrades
Check Out Our Latest Report on BBWI
Institutional Trading of Bath & Body Works
Hedge funds have recently bought and sold shares of the stock. Mutual of America Capital Management LLC boosted its holdings in shares of Bath & Body Works by 235.8% in the first quarter. Mutual of America Capital Management LLC now owns 111,471 shares of the company’s stock valued at $3,380,000 after buying an additional 78,280 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in shares of Bath & Body Works during the first quarter worth $807,000. Legato Capital Management LLC acquired a new position in Bath & Body Works in the 1st quarter worth $663,000. Royce & Associates LP boosted its stake in Bath & Body Works by 22.8% in the 1st quarter. Royce & Associates LP now owns 40,423 shares of the company’s stock worth $1,226,000 after purchasing an additional 7,505 shares during the period. Finally, Cetera Investment Advisers boosted its stake in Bath & Body Works by 8.9% in the 1st quarter. Cetera Investment Advisers now owns 27,091 shares of the company’s stock worth $821,000 after purchasing an additional 2,214 shares during the period. 95.14% of the stock is currently owned by institutional investors and hedge funds.
Bath & Body Works Trading Down 23.2%
The company has a 50 day simple moving average of $25.07 and a 200-day simple moving average of $28.34. The stock has a market cap of $3.33 billion, a price-to-earnings ratio of 4.81, a P/E/G ratio of 0.86 and a beta of 1.53.
About Bath & Body Works
Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Featured Stories
- Five stocks we like better than Bath & Body Works
- What is MarketRank™? How to Use it
- NVIDIA Just Proved the AI Boom Is Bigger Than Anyone Thought
- Where to Find Earnings Call Transcripts
- Why Target Stock May Keep Falling Despite a 5% Dividend Yield
- What is the Euro STOXX 50 Index?
- Is Tesla Setting Up for a Year-End Rebound—or a Collapse?
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.
